BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25365510)

  • 1. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H; Li Y; Kang M
    PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.
    Fang S; Peng L; Zhang M; Hou R; Deng X; Li X; Xin J; Peng L; Liu Z; Liu Y; Xie Y; Zhou B; Fang W; Liu Z; Cheng C
    Environ Toxicol; 2024 Jun; 39(6):3548-3562. PubMed ID: 38477013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
    Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.
    Shi Z; Wang R; Huang L; Chen X; Xu M; Zha D; Ma Y
    Aging (Albany NY); 2020 Jun; 12(12):11568-11578. PubMed ID: 32541092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
    Cheng JZ; Chen JJ; Wang ZG; Yu D
    Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN.
    Qu C; Liang Z; Huang J; Zhao R; Su C; Wang S; Wang X; Zhang R; Lee MH; Yang H
    Cell Cycle; 2012 Feb; 11(4):785-96. PubMed ID: 22374676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
    Li DP; Chai W; Liu YH; Xu TT; Huang H
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
    Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
    Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
    Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
    J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.